deltatrials
Unknown OBSERVATIONAL NCT01953458

Therapeutic Option for Hepatitis B and C: a French Cohort (HEPATHER)

Sponsor: ANRS, Emerging Infectious Diseases

Conditions Viral Hepatitis B Viral Hepatitis C
Updated 16 times since 2017 Last updated: Jan 30, 2023 Started: Aug 6, 2012 Primary completion: Dec 31, 2024 Completion: Dec 31, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01953458, this observational or N/A phase trial focuses on Viral Hepatitis B and Viral Hepatitis C and remains ongoing. Sponsored by ANRS, Emerging Infectious Diseases, it has been updated 16 times since 2012, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Oct 2017 · 2 months · monthly snapshot~Oct 2017 – ~Apr 2018 · 6 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Nov 2020 · 29 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshot~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshot~Dec 2021 – ~Jun 2022 · 6 months · monthly snapshot~Jun 2022 – ~Nov 2022 · 5 months · monthly snapshot~Nov 2022 – ~Feb 2023 · 3 months · monthly snapshot~Feb 2023 – ~Jul 2024 · 17 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – present · 17 months · monthly snapshot

Change History

16 versions recorded

  1. Feb 2025 — Present [monthly]

    Unknown

    Status: Active Not Recruiting → Unknown

  2. Sep 2024 — Feb 2025 [monthly]

    Active Not Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting

  4. Feb 2023 — Jul 2024 [monthly]

    Active Not Recruiting

    Status: Unknown Status → Active Not Recruiting

  5. Nov 2022 — Feb 2023 [monthly]

    Unknown Status

    Status: Recruiting → Unknown Status

▶ Show 11 earlier versions

  1. Jun 2022 — Nov 2022 [monthly]

    Recruiting

  2. Dec 2021 — Jun 2022 [monthly]

    Recruiting

  3. Oct 2021 — Dec 2021 [monthly]

    Recruiting

  4. Jan 2021 — Oct 2021 [monthly]

    Recruiting

  5. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  6. Jun 2018 — Nov 2020 [monthly]

    Recruiting

  7. May 2018 — Jun 2018 [monthly]

    Recruiting

  8. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  9. Oct 2017 — Apr 2018 [monthly]

    Recruiting NA

  10. Aug 2017 — Oct 2017 [monthly]

    Recruiting NA

  11. Jan 2017 — Aug 2017 [monthly]

    Recruiting NA

    First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • ANRS, Emerging Infectious Diseases
  • Bristol-Myers Squibb
  • Gilead Sciences
  • Janssen-Cilag Ltd.
  • Merck Sharp & Dohme LLC
  • Roche Pharma AG
Data source: ANRS, Emerging Infectious Diseases

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations